These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Biological characterization of CD34+ cells mobilized into peripheral blood. Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S. Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890 [Abstract] [Full Text] [Related]
6. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ. Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449 [Abstract] [Full Text] [Related]
7. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates. Hematti P, Tuchman S, Larochelle A, Metzger ME, Donahue RE, Tisdale JF. Stem Cells; 2004 Oct; 22(6):1062-9. PubMed ID: 15536196 [Abstract] [Full Text] [Related]
8. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Fritsch G, Stimpfl M, Kurz M, Printz D, Buchinger P, Fischmeister G, Hoecker P, Gadner H. Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162 [Abstract] [Full Text] [Related]
9. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Traycoff CM, Abboud MR, Laver J, Brandt JE, Hoffman R, Law P, Ishizawa L, Srour EF. Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862 [Abstract] [Full Text] [Related]
12. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood. Van Zant G, Rummel SA, Koller MR, Larson DB, Drubachevsky I, Palsson M, Emerson SG. Blood Cells; 1994 Feb; 20(2-3):482-90; discussion 491. PubMed ID: 7538353 [Abstract] [Full Text] [Related]
14. Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation. De Bruyn C, Delforge A, Lagneaux L, Bron D. Bone Marrow Transplant; 2000 Feb; 25(4):377-83. PubMed ID: 10723580 [Abstract] [Full Text] [Related]
15. Evaluation of a cytokine combination including thrombopoietin for improved transduction of a retroviral gene into G-CSF-mobilized CD34+ human blood cells. Kim HJ, Okamoto Y, Ito M, Takaue Y, Kawano Y, Watanabe T, Yamaue T, Tohda Y, Ogose T, Shimada T, Shimosaka A, Kuroda Y. Stem Cells; 1997 Feb; 15(5):347-52. PubMed ID: 9323796 [Abstract] [Full Text] [Related]
17. Long-term cultures to evaluate engraftment potential of CD34+ cells from peripheral blood after mobilization by chemotherapy with and without GM-CSF. Benboubker L, Domenech J, Linassier C, Desbois I, Delain M, Lamagnere JP, Colombat P, Binet C. Exp Hematol; 1995 Dec; 23(14):1568-73. PubMed ID: 8542948 [Abstract] [Full Text] [Related]
18. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF. Cesana C, Carlo-Stella C, Regazzi E, Garau D, Sammarelli G, Caramatti C, Tabilio A, Mangoni L, Rizzoli V. Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059 [Abstract] [Full Text] [Related]